News

The firm is developing a kitted version of the four-biomarker combination test, and it plans to commercialize them in the EU and US markets.
Two’s company, but a lump is a crowd! April is Testicular Cancer Awareness Month, a time to take charge of your health by not ...
Malignant testicular germ cell tumors are the most common cancers diagnosed in males ages 15 to 39 in the U.S., though incidence has increased by almost 40% in the last 50 years. At the same time, ...
The unnamed 52-year-old man did not know he had the disease and he originally visited a doctor complaining of a painless ...
We want to highlight recent discoveries in the field and raise awareness about the significance of early diagnosis, multidisciplinary management, and the pivotal role of technological innovation in ...
“Let's be honest, guys are always touching their balls!” said Charles McCluskey, MD, testicular cancer survivor and urology resident at the Medical College of Georgia. “Education about testicular self ...
Researchers have validated a specific cluster of microRNAs (miRNAs) as reliable biomarkers for detecting malignant testicular ...
Cornell researchers have confirmed that a previously identified biomarker for detecting the presence of malignant testicular germ cell tumors – the most common solid cancers in young men – has the ...
Malignant testicular germ cell tumors are the most common cancers diagnosed in males ages 15 to 39 in the U.S., though incidence has increased by almost 40% in the last 50 years.
There is an increased risk of testicular cancer in people with undescended testicles. Germ cell neoplasia in situ (GCNIS) means that there are abnormal cells in the testicle. It isn't cancer. There is ...
Christ ordered testicular tumor markers and a scrotal ... enlarged scrotum veins and a “suspicious” germ cell tumor. But a CAT scan came back negative. Christ recommended an MRI of the right ...